首页> 外文期刊>Therapeutic Drug Monitoring >Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
【24h】

Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.

机译:苯妥英钠在日本癫痫患者中的剂量调整。

获取原文
获取原文并翻译 | 示例
           

摘要

This study sought a suitable physiological parameter related to daily phenytoin (PHT) dose (D) providing a steady-state serum concentration (Ct) and analyzed the influences of coadministered antiepileptic drugs on Ct quantitatively to adjust PHT dose. Data were derived from a total of 368 patients with epilepsy treated with multiple oral administrations of PHT. Phenobarbital, carbamazepine, valproic acid, zonisamide, clonazepam, and ethosuximide were coadministered. For the administration of PHT alone, 4 types of parameter, that is, total body weight, total body water volume, body surface area, and extracellular water volume (VECW) were examined. Then, a Michaelis-Menten kinetic model was postulated including VECW, which was assumed to detect the effect of the coadministered drug quantitatively. Adopting VECW as a transforming factor, the concentration to dose (L:D) ratio [Ct/(D/VECW)] was independent of the patient's age and gender in relation to Ct and expressed as Ct/(D/VECW) = 0.0245 x Ct + 0.076. Analysis clarified that ratios were estimated as 0.90, 0.91, 0.89, and 0.84 for phenobarbital, carbamazepine, valproic acid, and zonisamide, respectively, to maintain the same Ct concentration of PHT. Influences were not detected as the number (> or =2) of coadministered drugs increased, regardless of factor type. PHT clearance changed in an age-dependent manner and was usually poorly correlated with weight-based doses. VECW was more closely correlated with age-dependent changes in physiological parameters such as clearance. VECW was considered to remove the influence of age on clearance, and estimated ratios could be used for all age groups. In the case of the addition or removal of concomitant treatment with antiepileptic drugs in the same patient, the daily PHT dose was calculated using the value of each ratio or its reciprocal. Our results could be helpful in determining PHT dosing.
机译:这项研究寻求与每日苯妥英钠(PHT)剂量(D)相关的合适的生理参数,以提供稳态血清浓度(Ct),并定量分析了抗癫痫药物联合给药对Ct的影响,以调节PHT剂量。数据来自总共368例多次口服PHT治疗的癫痫患者。苯巴比妥,卡马西平,丙戊酸,唑尼沙胺,氯硝西am和乙琥胺合用。对于单独施用PHT,检查了四种类型的参数,即总体重,总体水量,体表面积和细胞外水量(VECW)。然后,假定包括VECW在内的Michaelis-Menten动力学模型被假定为定量检测共同给药药物的作用。采用VECW作为转换因子,浓度与剂量(L:D)的比率[Ct /(D / VECW)]与患者的年龄和性别(与Ct相关)无关,并表示为Ct /(D / VECW)= 0.0245 x Ct + 0.076。分析表明,苯巴比妥,卡马西平,丙戊酸和唑尼沙胺的比率分别估计为0.90、0.91、0.89和0.84,以维持相同的Pt Ct浓度。不论因子类型如何,共用药物数量(>或= 2)增加均未检测到影响。 PHT清除率以年龄依赖性变化,通常与基于体重的剂量相关性较弱。 VECW与年龄相关的生理参数变化(如清除率)更紧密相关。人们认为,VECW消除了年龄对通行率的影响,估计比例可用于所有年龄组。如果在同一患者中增加或取消抗癫痫药物的同时治疗,则使用每个比率的值或其倒数来计算每日PHT剂量。我们的结果可能有助于确定PHT剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号